Mckesson's Corporate Customers have recorded an advance in their cost of revenue by 9.07 % in the 1 quarter 2026 year on year, sequentially costs of revenue grew by 6.09 %. During the corresponding time, Mckesson Corporation recorded a revenue increase by 7.72 % year on year, sequentially revenue grew by 9.43 %. While revenue at the Mckesson Corporation's corporate clients recorded rose by 7.25 % year on year, sequentially revenue grew by 5.55 %.
Mckesson's Customers have recorded an advance in their cost of revenue by 9.07 % in the 1 quarter 2026 year on year, sequentially costs of revenue grew by 6.09 %, for the same period Mckesson Corporation recorded revenue increase by 7.72 % year on year, sequentially revenue grew by 9.43 %.
Mckesson's Comment on Sales, Marketing and Customers
The major offerings of the McKesson U.S. Pharmaceutical Distribution business
by customer group can be categorized as retail national accounts, institutional
healthcare providers and independent retail pharmacies.
Retail National Accounts — Business solutions that help national account
customers increase revenues and profitability. Solutions include:
Central FillSM — Prescription refill service that enables pharmacies to
more quickly refill prescriptions remotely, more accurately and at a lower cost,
while reducing inventory levels and improving customer service.
Redistribution Centers — Two facilities totaling over 750,000 square feet
that offer access to inventory for single source warehouse purchasing, including
pharmaceuticals and biologics. These distribution centers also provide the foundation
for a two-tiered distribution network that supports best-in-class direct store
delivery.
McKesson SynerGx® — Generic pharmaceutical purchasing program and inventory
management that helps pharmacies maximize their cost savings with a broad selection
of generic drugs, low pricing and one-stop shopping.
EnterpriseRx® — A Software as a Service (SaaS) pharmacy management system,
that allows large retail chain, health system and retail independent pharmacies
to meet demand for prescriptions while maximizing profits and optimizing operations.
RxPakSM — Bulk-to-bottle repackaging service that leverages our purchasing
scale and supplier relationships to provide pharmaceuticals at reduced prices,
help increase inventory turns and reduce working capital investment.
Inventory Management — An integrated solution comprising forecasting software
and automated replenishment technologies that reduce inventory-carrying costs.
ExpressRx Track™ — Pharmacy automation solution featuring state-of-the-art
robotics, upgraded imaging and expanded vial capabilities, and industry-leading
speed and accuracy in a radically small footprint.
Supplylogix® — develops and delivers practical supply chain intelligence
solutions for pharmacy and related businesses and services a wide array of healthcare
providers nationwide.
Institutional Healthcare Providers — Electronic ordering/purchasing and
supply chain management systems that help customers improve financial performance,
increase operational efficiencies and deliver better patient care. Solutions
include:
Fulfill-RxSM — Ordering and inventory management system that empowers
hospitals to optimize the often complicated and disjointed processes related
to unit-based cabinet replenishment and inventory management.
Asset Management — Award-winning inventory optimization and purchasing
management program that helps institutional providers lower costs while ensuring
product availability.
SKY Packaging — Blister-format packaging containing the most widely prescribed
dosages and strengths in generic oral-solid medications. SKY Packaging enables
acute care, long-term care and institutional pharmacies to provide cost-effective,
uniform packaging.
McKesson Plasma and BioLogics — A full portfolio of plasma-derivatives
and biologic products.
McKesson OneStop Generics® — Generic pharmaceutical purchasing program
that helps pharmacies maximize their cost savings with a broad selection of
generic drugs, low pricing and one-stop shopping.
McKesson 340B Solution Suite and Macro Helix® — Solutions that help
providers manage, track and report on medication replenishment associated with
the federal 340B Drug Pricing Program
Independent Retail Pharmacies — Solutions for managed care contracting,
branding and advertising, merchandising, purchasing, operational efficiency
and automation that help independent pharmacists focus on patient care while
improving profitability. Solutions include:
Health Mart® — Health Mart® is a national network of more than
3,000 independently-owned pharmacies and is one of the industry’s most
comprehensive pharmacy franchise programs. Health Mart® provides franchisees
support for managed care contracting, branding and local marketing solutions,
the Health Mart private label line of products, merchandising solutions and
programs for enhanced patient support.
AccessHealth® — Comprehensive managed care and reconciliation assistance
services that help independent pharmacies save time, access competitive reimbursement
rates and improve cash flow.
McKesson Reimbursement AdvantageSM (“MRA”) — MRA is one of
the industry’s most comprehensive reimbursement optimization packages,
comprising financial services (automated claim resubmission), analytic services
and customer care.
McKesson OneStop Generics® — described above.
EnterpriseRx® — described above.
Sunmark® — Complete line of more than 700 products that provide retail
independent pharmacies with value-priced alternatives to national brands.
FrontEdge™ — Strategic planning, merchandising and price maintenance
program that helps independent pharmacies maximize store profitability.
McKesson Sponsored Clinical Services (SCS) Network — Access to patient-support
services that allow pharmacists to earn service fees and develop stronger patient
relationships
Celesio’s pharmaceutical wholesale business supplies pharmaceuticals
and other healthcare-related products generally to retail pharmacies and institutional
customers. Celesio’s wholesale network consisting of 133 branches delivers
to over 65,000 pharmacies daily in ten European countries and Brazil. Celesio
functions as a vital link between manufacturers and pharmacies in supplying
pharmaceuticals to patients, and generally procures the medicines approved in
each country as well as other products sold in pharmacies directly from the
manufacturers. Celesio stores pharmaceutical and other products at regional
wholesale branches with the support of its efficient warehousing management
system. With a refined distribution system, Celesio strives to ensure rapid
and reliable delivery directly to its pharmacy customers.
Sales to our ten largest customers accounted for approximately 48% of our
total consolidated revenues. Sales to our largest customer, CVS Caremark Corporation
("CVS"), accounted for approximately 16% of our total consolidated
revenues. Trade accounts receivable from our ten largest customers were approximately
32% of total trade accounts receivable. Accounts receivable from CVS were approximately
12% of total trade accounts receivable. We also have agreements with group purchasing
organizations (“GPOs”), each of which functions as a purchasing
agent on behalf of member hospitals, pharmacies and other healthcare providers.
The accounts receivables balances are with individual members of the GPOs. Substantially
all of these revenues and accounts receivable are included in our Distribution
Solutions segment.
CSIMarket.com A Transaction of Distinction: McKesson Corporation Sells Rexall and Well.ca to Birch Hill Equity Partners In the grand theater of American commerce, we find ourselves witnessing a significant and strategic realignment as McKesson Corporation, that venerable institution of the healthcare domain, announces the divestiture of its Canadian enterprises, Rexall and Well.ca, to Birch Hill Equity Partners, a distinguished private equity firm hailing from the Great White North. This immense transaction, anchored in the steadfast pursuit of enterprise refinement, aligns seamlessly with McKesson’s overarching ambition to markedly enhance its oncology and biopharmaceutical service offerings.The news...
In a significant strategic maneuver aimed at bolstering its presence in the oncology sector, McKesson Corporation (NYSE: MCK) has announced a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). This move is set against the backdrop of evolving dynamics within the healthcare landscape, particularly in community oncology where supportive services and integrated care are becoming increasingly essential. Strategic Acquisition and Its Implications Core Ventures, established by the renowned Florida Cancer Specialists and Research Institute, LLC (FCS) a prominent physician-owned community oncology practice serves as a vital business a...
Mckesson’s Comment on Sales, Marketing and Customers
The major offerings of the McKesson U.S. Pharmaceutical Distribution business
by customer group can be categorized as retail national accounts, institutional
healthcare providers and independent retail pharmacies.
Retail National Accounts — Business solutions that help national account
customers increase revenues and profitability. Solutions include:
Central FillSM — Prescription refill service that enables pharmacies to
more quickly refill prescriptions remotely, more accurately and at a lower cost,
while reducing inventory levels and improving customer service.
Redistribution Centers — Two facilities totaling over 750,000 square feet
that offer access to inventory for single source warehouse purchasing, including
pharmaceuticals and biologics. These distribution centers also provide the foundation
for a two-tiered distribution network that supports best-in-class direct store
delivery.
McKesson SynerGx® — Generic pharmaceutical purchasing program and inventory
management that helps pharmacies maximize their cost savings with a broad selection
of generic drugs, low pricing and one-stop shopping.
EnterpriseRx® — A Software as a Service (SaaS) pharmacy management system,
that allows large retail chain, health system and retail independent pharmacies
to meet demand for prescriptions while maximizing profits and optimizing operations.
RxPakSM — Bulk-to-bottle repackaging service that leverages our purchasing
scale and supplier relationships to provide pharmaceuticals at reduced prices,
help increase inventory turns and reduce working capital investment.
Inventory Management — An integrated solution comprising forecasting software
and automated replenishment technologies that reduce inventory-carrying costs.
ExpressRx Track™ — Pharmacy automation solution featuring state-of-the-art
robotics, upgraded imaging and expanded vial capabilities, and industry-leading
speed and accuracy in a radically small footprint.
Supplylogix® — develops and delivers practical supply chain intelligence
solutions for pharmacy and related businesses and services a wide array of healthcare
providers nationwide.
Institutional Healthcare Providers — Electronic ordering/purchasing and
supply chain management systems that help customers improve financial performance,
increase operational efficiencies and deliver better patient care. Solutions
include:
Fulfill-RxSM — Ordering and inventory management system that empowers
hospitals to optimize the often complicated and disjointed processes related
to unit-based cabinet replenishment and inventory management.
Asset Management — Award-winning inventory optimization and purchasing
management program that helps institutional providers lower costs while ensuring
product availability.
SKY Packaging — Blister-format packaging containing the most widely prescribed
dosages and strengths in generic oral-solid medications. SKY Packaging enables
acute care, long-term care and institutional pharmacies to provide cost-effective,
uniform packaging.
McKesson Plasma and BioLogics — A full portfolio of plasma-derivatives
and biologic products.
McKesson OneStop Generics® — Generic pharmaceutical purchasing program
that helps pharmacies maximize their cost savings with a broad selection of
generic drugs, low pricing and one-stop shopping.
McKesson 340B Solution Suite and Macro Helix® — Solutions that help
providers manage, track and report on medication replenishment associated with
the federal 340B Drug Pricing Program
Independent Retail Pharmacies — Solutions for managed care contracting,
branding and advertising, merchandising, purchasing, operational efficiency
and automation that help independent pharmacists focus on patient care while
improving profitability. Solutions include:
Health Mart® — Health Mart® is a national network of more than
3,000 independently-owned pharmacies and is one of the industry’s most
comprehensive pharmacy franchise programs. Health Mart® provides franchisees
support for managed care contracting, branding and local marketing solutions,
the Health Mart private label line of products, merchandising solutions and
programs for enhanced patient support.
AccessHealth® — Comprehensive managed care and reconciliation assistance
services that help independent pharmacies save time, access competitive reimbursement
rates and improve cash flow.
McKesson Reimbursement AdvantageSM (“MRA”) — MRA is one of
the industry’s most comprehensive reimbursement optimization packages,
comprising financial services (automated claim resubmission), analytic services
and customer care.
McKesson OneStop Generics® — described above.
EnterpriseRx® — described above.
Sunmark® — Complete line of more than 700 products that provide retail
independent pharmacies with value-priced alternatives to national brands.
FrontEdge™ — Strategic planning, merchandising and price maintenance
program that helps independent pharmacies maximize store profitability.
McKesson Sponsored Clinical Services (SCS) Network — Access to patient-support
services that allow pharmacists to earn service fees and develop stronger patient
relationships
Celesio’s pharmaceutical wholesale business supplies pharmaceuticals
and other healthcare-related products generally to retail pharmacies and institutional
customers. Celesio’s wholesale network consisting of 133 branches delivers
to over 65,000 pharmacies daily in ten European countries and Brazil. Celesio
functions as a vital link between manufacturers and pharmacies in supplying
pharmaceuticals to patients, and generally procures the medicines approved in
each country as well as other products sold in pharmacies directly from the
manufacturers. Celesio stores pharmaceutical and other products at regional
wholesale branches with the support of its efficient warehousing management
system. With a refined distribution system, Celesio strives to ensure rapid
and reliable delivery directly to its pharmacy customers.
Sales to our ten largest customers accounted for approximately 48% of our
total consolidated revenues. Sales to our largest customer, CVS Caremark Corporation
("CVS"), accounted for approximately 16% of our total consolidated
revenues. Trade accounts receivable from our ten largest customers were approximately
32% of total trade accounts receivable. Accounts receivable from CVS were approximately
12% of total trade accounts receivable. We also have agreements with group purchasing
organizations (“GPOs”), each of which functions as a purchasing
agent on behalf of member hospitals, pharmacies and other healthcare providers.
The accounts receivables balances are with individual members of the GPOs. Substantially
all of these revenues and accounts receivable are included in our Distribution
Solutions segment.
Sources:
Mckesson Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Mckesson Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Mckesson Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
82.34 %
6.14 %